Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ginza Phoenix Clinic is a specialized medical institution located in the Ginza district of Tokyo, Japan, focusing on advanced cancer immunotherapy and regenerative medicine. The clinic provides autologous immune cell therapies, including Natural Killer (NK) cell therapy and Dendritic cell (DC) therapy, which involve the cultivation and activation of a patient's own immune cells to target and eliminate malignant cells. As a prominent center for medical tourism, it offers personalized oncology treatment plans to both domestic and international patients seeking innovative alternatives to standard care. The facility operates its own Cell Processing Center (CPC) in compliance with Japanese regenerative medicine regulations to ensure the quality and safety of its cell-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GINZA Phoenix.